1st Quarter - Report

WILLIAMS AND JENSEN, PLLC for ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Tax issues affecting the pharmaceutical industry.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER LD, Rep. Scott McInnis
GEORGE OLSEN —
JOEL OSWALD Prof.Staff,, Senate Banking Comte; LA,Sen.Enzi.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009 Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform; Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

LobbyistCovered position, as disclosed
JENNY DIJAMES New LA and LD, Rep. Bud Cramer
SUSAN HIRSCHMANN New COS, Rep.Van Hilleary & Majority Whip
KARINA LYNCH Staff, Senate Committee on Government Affairs
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 573 (111th), S. 369 (111th), H.R. 1706 (111th), S. 487 (111th), S. 357 (111th), S. 301 (111th), H.R. 1298 (111th), H.R. 579 (111th), H.R. 1548 (111th), S. 726 (111th), S. 501 (111th), H.R. 873 (111th), H.R. 1 (111th), H.R. 1427 (111th), S. 525 (111th)

Medicare/Medicaid MMM

Medicaid drug rebates including S. 547/H.R. 904, Drug Rebate Equalization Act of 2009; H.R. 1725, Voluntary State Discount Prescription Drug Plan Act of 2009; and Medicare drug price negotiation, payment, and coverage including S. 330/H.R. 684, Medicare Prescription Drug Savings and Choice Act of 2009; S. 266, Medicare Prescription Drug Gap Reduction Act of 2009.

LobbyistCovered position, as disclosed
JENNY DIJAMES LA and LD, Rep. Bud Cramer
JACK STEVEN HART —
KARINA LYNCH Staff, Senate Committee on Government Affairs
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 904 (111th), S. 547 (111th), S. 266 (111th), S. 330 (111th), H.R. 1725 (111th), H.R. 684 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.